Stay updated with breaking news from Updated Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RESEARCH TRIANGLE PARK, N.C., May 23, 2024 -- G1 Therapeutics, Inc. , a commercial-stage oncology company, today announced that mature Phase 2 results describing the positive impact of trilaciclib...
Updated Phase 1 monotherapy data for XTX101 at the recommended Phase 2 dose (RP2D) continues to demonstrate minimal treatment-related adverse events,…
– Updated Phase 2 data for ADCETRIS in combination with nivolumab in early and advanced stage classical Hodgkin lymphoma to be presented in oral session –– First preclinical data for investigational antibody-drug conjugate SGN-35C to be presented –BOTHELL, Wash.--(BUSINESS WIRE)--#ASH23--Seagen Inc. (NASDAQ: SGEN) t...
NES-ZIONA, ISRAEL / ACCESSWIRE / April 12, 2023 / This month, Enlivex Therapeutics Ltd. (NASDAQ:ENLV) announced a new clinical collaboration agreement with Beigene Ltd to test a new combination treatment
27.03.2023 - - Internal focus on next generation therapeutic pipeline including ongoing Phase 1 for CX-904 (EGFRxCD3) and anticipated IND filings for CX-2051 (EpCAM-directed ADC) and CX-801 (Interferon alpha-2b) in the second half of 2023 - - Bristol Myers ...